| EREG |
EREG: Proepiregulin precursor [Contains: Epiregulin |
EFNA2 |
EFNA2, EPLG6, LERK6: Ephrin-A2 precursor |
5.542 |
Evidence |
|
| TOB1 |
TOB1, TOB, TROB1: Protein Tob1 |
RPS6KA3 |
RPS6KA3, ISPK1, RSK2: Ribosomal protein S6 kinase alpha-3 |
5.52 |
Evidence |
|
| YWHAB |
YWHAB: 14-3-3 protein beta/alpha |
PDCL |
PDCL: Phosducin-like protein |
5.52 |
Evidence |
|
| FLNA |
FLNA, FLN, FLN1: Filamin-A |
TUBA1 |
TUBA4A, TUBA1: Tubulin alpha-4A chain |
5.515 |
Evidence |
|
| TCF3 |
TCF3, E2A, ITF1: Transcription factor E2-alpha |
MGMT |
MGMT: Methylated-DNA--protein-cysteine methyltransferase |
5.515 |
Evidence |
|
| ABL1 |
ABL1, ABL, JTK7: Proto-oncogene tyrosine-protein kinase ABL1 |
MCM3 |
MCM3: DNA replication licensing factor MCM3 |
5.515 |
Evidence |
|
| RANBP5 |
|
KPNA3 |
KPNA3: Importin subunit alpha-3 |
5.512 |
Evidence |
|
| SIPA1L2 |
SIPA1L2, KIAA1389: Signal-induced proliferation-associated 1-like protein 2 |
ACTN1 |
ACTN1: Alpha-actinin-1 |
5.505 |
Evidence |
|
| SIN3A |
SIN3A: Paired amphipathic helix protein Sin3a |
SALL1 |
SALL1, SAL1: Sal-like protein 1 |
5.505 |
Evidence |
|
| FRS2 |
FRS2: Fibroblast growth factor receptor substrate 2 |
PARD6A |
PARD6A, PAR6A: Partitioning defective 6 homolog alpha |
5.505 |
Evidence |
|
| IKBKE |
IKBKE, IKKE, IKKI, KIAA0151: Inhibitor of nuclear factor kappa-B kinase subunit |
CDC37 |
CDC37: Hsp90 co-chaperone Cdc37 |
5.505 |
Evidence |
O
|
| SP3 |
SP3: Transcription factor Sp3 |
SIN3A |
SIN3A: Paired amphipathic helix protein Sin3a |
5.505 |
Evidence |
|
| GRB2 |
GRB2, ASH: Growth factor receptor-bound protein 2 |
FRS2 |
FRS2: Fibroblast growth factor receptor substrate 2 |
5.505 |
Evidence |
|
| PTEN |
PTEN, MMAC1, TEP1: Phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase and du |
IKBKE |
IKBKE, IKKE, IKKI, KIAA0151: Inhibitor of nuclear factor kappa-B kinase subunit |
5.505 |
Evidence |
|
| BCAR1 |
BCAR1, CAS, CRKAS: Breast cancer anti-estrogen resistance protein 1 |
FLT4 |
VEGFR3 long form |
5.505 |
Evidence |
|
| BCAR1 |
BCAR1, CAS, CRKAS: Breast cancer anti-estrogen resistance protein 1 |
ADAM33 |
ADAM33, UNQ873/PRO1891: ADAM 33 precursor |
5.505 |
Evidence |
|
| BCAR1 |
BCAR1, CAS, CRKAS: Breast cancer anti-estrogen resistance protein 1 |
PTK2B |
PTK2B, FAK2, PYK2, RAFTK: Protein tyrosine kinase 2 beta |
5.505 |
Evidence |
|
| BCAR1 |
BCAR1, CAS, CRKAS: Breast cancer anti-estrogen resistance protein 1 |
CNTN1 |
CNTN1: Contactin-1 precursor |
5.505 |
Evidence |
|
| BCAR1 |
BCAR1, CAS, CRKAS: Breast cancer anti-estrogen resistance protein 1 |
ITK |
ITK, EMT, LYK: Tyrosine-protein kinase ITK/TSK |
5.505 |
Evidence |
|
| BCAR1 |
BCAR1, CAS, CRKAS: Breast cancer anti-estrogen resistance protein 1 |
PRKCZ |
PRKCZ, PKC2: Protein kinase C zeta type |
5.505 |
Evidence |
|
| EIF5 |
EIF5: Eukaryotic translation initiation factor 5 |
SFRS9 |
SFRS9, SRP30C: Splicing factor, arginine/serine-rich 9 |
5.505 |
Evidence |
|
| EPHA4 |
EPHA4, HEK8, SEK, TYRO1: Ephrin type-A receptor 4 precursor |
BCAR1 |
BCAR1, CAS, CRKAS: Breast cancer anti-estrogen resistance protein 1 |
5.505 |
Evidence |
|
| EPHB1 |
EPHT2, EPHB1, NET: Ephrin type-B receptor 1 precursor |
PHC3 |
PHC3, EDR3, PH3: Polyhomeotic-like protein 3 |
5.505 |
Evidence |
|
| EPHB3 |
EPHB3, ETK2, HEK2, TYRO6: Ephrin type-B receptor 3 precursor |
BCAR1 |
BCAR1, CAS, CRKAS: Breast cancer anti-estrogen resistance protein 1 |
5.505 |
Evidence |
|
| STAT5B |
STAT5B: Signal transducer and activator of transcription 5B |
BCAR1 |
BCAR1, CAS, CRKAS: Breast cancer anti-estrogen resistance protein 1 |
5.505 |
Evidence |
|